Eli Lilly Stock Tumbles On Lowered Guidance As Weight-Loss Drug Sales Slow

Technology

Eli Lilly Stock Tumbles On Lowered Guidance As Weight-Loss Drug Sales Slow

By Investor's Business Daily

Eli Lilly (LLY) on Tuesday lowered guidance for its December quarter amid slower-than-expected sales for its Zepbound and Mounjaro weight loss drugs. Eli Lilly stock tumbled on the news. For the December quarter, the Indianapolis-based company said i ...Read more